中文产业新闻精选评分61Chinese source
礼来 Mounjaro 凭 SURPASS-CVOT 非劣效结果再获 FDA 批准用于降低 2 型糖尿病 MACE 风险
超1.3万人3期研究支持！礼来Mounjaro再获FDA批准
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
超1.3万人3期研究支持！礼来Mounjaro再获FDA批准
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.